When determining the success of cardiology therapies, trials should focus more on softer end points like quality of life and psychological well-being, said Donna Fitzsimons, PhD, FESC, professor of nursing at the School of Nursing and Midwifery, Queen's University Belfast.
Donna Fitzsimons, PhD, FESC, professor of nursing at the School of Nursing and Midwifery, Queen's University Belfast, highlights the importance of patient-reported outcomes (PROs) in patient-centered cardiology care.
Transcript
Can you tell our audience what you discussed during your session on patient-centered care delivery?
We had a really interesting session today at the ESC Congress on patient-centered care. We had presentations from Jeroen Hendricks, [PhD, MSc, RN), who really looked at atrial fibrillation, and then we had Femke [Piersma] who is a nurse practitioner in arrhythmia management, and then—as well as myself—we also had Gerhard Hindricks, [MD, PhD], who is a leading trialist in the area of atrial fibrillation. The focus was very much about how we can remodel our care pathway to make it more patient centered.
What are some key factors contributing to the growing adoption of PROs in cardiology?
For many years, cardiology in particular and cardiovascular care more generally [have] focused on hard end points, like mortality and hospital admission, to predict outcomes and to evaluate the success of therapies. What we're finding is that those trials are really difficult to do because you need much larger numbers and a much longer time to observe those outcomes. In actual fact, those aren't the things that matter most to patients.
Patients are really interested in softer end points, like quality of life, and issues such as their psychological and their social well-being on therapies as they live with and adjust to their cardiovascular condition. So, I would say a little bit slower than other disease entities such as cancer, for instance, the cardiovascular world is catching up and realizing that for us to be really hitting the mark and achieving what matters to patients, we need to look at a wider range of factors and include those whenever we're evaluating the success of our therapies.
What is the process of creating and validating disease-specific and domain-specific PROs in cardiology, and how do they differ from more generic PROs?
It's really important that we are able to have generic patient-reported outcomes so that we can evaluate the impact of cardiovascular disease in comparison to other conditions. But, specifically, whenever we look at it, we obviously realize that cardiovascular disease is a chronic condition and that we need to monitor patients over a protracted period of time. So we need good tools that are sensitive to the changes in those very important but what we would term "softer" outcomes, such as quality of life, such as anxiety, depression, and other psychosocial issues.
What's at Stake as Oral Arguments Are Presented in the Braidwood Case? Q&A With Richard Hughes IV
April 21st 2025Richard Hughes IV, JD, MPH, spoke about the upcoming oral arguments to be presented to the Supreme Court regarding the Braidwood case, which would determine how preventive services are guaranteed insurance coverage.
Read More
New Research Challenges Assumptions About Hospital-Physician Integration, Medicare Patient Mix
April 22nd 2025On this episode of Managed Care Cast, Brady Post, PhD, lead author of a study published in the April 2025 issue of The American Journal of Managed Care®, challenges the claim that hospital-employed physicians serve a more complex patient mix.
Listen
Personalized Care Key as Tirzepatide Use Expands Rapidly
April 15th 2025Using commercial insurance claims data and the US launch of tirzepatide as their dividing point, John Ostrominski, MD, Harvard Medical School, and his team studied trends in the use of both glucose-lowering and weight-lowering medications, comparing outcomes between adults with and without type 2 diabetes.
Listen
Empowering Teams Begins With Human Connection: Missy Hopson, PhD
April 16th 2025Missy Hopson, PhD, Ochsner Health, discussed in detail the challenges of strengthening the patient-centered workforce, the power of community reputation for encouraging health care careers, and the influence of empowered workforces on patient outcomes.
Read More